Structure-based virtual screening of natural compounds against wild and mutant (R1155K, A1156T and D1168A) NS3-4A protease of Hepatitis C virus.
Samantaray M, Pattabiraman R, Murthy TPK, Ramaswamy A, Murahari M, Krishna S, Kumar SB.
Samantaray M, et al. Among authors: ramaswamy a.
J Biomol Struct Dyn. 2023 Aug 30:1-18. doi: 10.1080/07391102.2023.2246583. Online ahead of print.
J Biomol Struct Dyn. 2023.
PMID: 37646701
NS3-4A, a serine protease, is a primary target for drug development against Hepatitis C Virus (HCV). ...Telaprevir, a widely used protease inhibitor, was recruited as the control drug. ...
NS3-4A, a serine protease, is a primary target for drug development against Hepatitis C Virus (HCV). ...Telaprevir, a w …